Meat Evolution (MEVO) Summit
The 2023 MEVO Summit will focus on global alt protein regulatory developments, highlighting new markets, opportunities, and innovation.
The 2023 MEVO Summit will focus on global alt protein regulatory developments, highlighting new markets, opportunities, and innovation.
Alternative proteins can help prevent the next pandemic by meeting the rising demand for animal products without risking zoonotic disease or antibiotic-resistant bacteria.
The alternative protein industry today shows signs of resilience despite challenges across the macroeconomic landscape, geopolitical dynamics, and talent, funding, and infrastructure constraints. GFI experts predict the industry trends that will drive the next wave of developments toward mass adoption.
As we come closer to full regulatory approval, join GFI experts to review the current status of the cultivated meat industry and to take a deep dive into the recent advancements that have taken place in the United States.
Cultivated meat can transform our global food system. Get the latest updates on this game-changing alternative to conventionally produced meat.
GFI’s community of supporters sparked unprecedented innovation and growth for the alternative protein ecosystem in 2022—check out our highlights from the past year.
The U.S. Food and Drug Administration gave the go-ahead to a cultivated meat product for the first time, prompting questions about this novel production method and the future of meat. We answer the top six.
Sterilization guidelines from well-established biomedical and food industries can act as helpful templates for safe cultivated meat production. However, more research is needed to identify potentially novel production hazards for regulators to understand the unique requirements for cultivated meat.
GFI Israel's Nir Goldstein shares why Israel has such strong government support for alternative proteins.
Countries are sharing updates on the regulatory frameworks that can help scale the alt protein industry around the world